Cargando…

Development of Inducible CD19-CAR T Cells with a Tet-On System for Controlled Activity and Enhanced Clinical Safety

The tetracycline regulatory system has been widely used to control the transgene expression. With this powerful tool, it might be possible to effectively control the functional activity of chimeric antigen receptor (CAR) T cells and manage the severe side effects after infusion. In this study, we de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Xingjian, He, Dongyang, Li, Caixin, Wang, Hua, Yang, Guanghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275001/ https://www.ncbi.nlm.nih.gov/pubmed/30400287 http://dx.doi.org/10.3390/ijms19113455

Ejemplares similares

Feasibility of controlling CD38-CAR T cell activity with a Tet-on inducible CAR design
por: Drent, Esther, et al.
Publicado: (2018)

Optimisation of Tet-On inducible systems for Sleeping Beauty-based chimeric antigen receptor (CAR) applications
por: Ali Hosseini Rad, S. M., et al.
Publicado: (2020)

A novel adenoviral vector carrying an all-in-one Tet-On system with an autoregulatory loop for tight, inducible transgene expression
por: Chen, Hao, et al.
Publicado: (2015)

Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapy
por: Li, Wenjie, et al.
Publicado: (2023)

Promoter Strength Driving TetR Determines the Regulatory Properties of Tet-Controlled Expression Systems
por: Georgi, Christiane, et al.
Publicado: (2012)

Tet-On Systems For Doxycycline-inducible Gene Expression
por: Das, Atze T., et al.
Publicado: (2016)

Engineering CAR T cells for enhanced efficacy and safety
por: Wu, Yiqian, et al.
Publicado: (2022)

CD22-CAR T Cells Induce Remissions in CD19-CAR Naïve and Resistant B-ALL
por: Fry, Terry J., et al.
Publicado: (2017)

Case Report: Humanized Selective CD19CAR-T Treatment Induces MRD-Negative Remission in a Pediatric B-ALL Patient With Primary Resistance to Murine-Based CD19CAR-T Therapy
por: Wang, Kai, et al.
Publicado: (2020)

Development of a Tet-On Inducible Expression System for the Anhydrobiotic Cell Line, Pv11
por: Tokumoto, Shoko, et al.
Publicado: (2020)

Development of an All-in-One Lentiviral Vector System Based on the Original TetR for the Easy Generation of Tet-ON Cell Lines
por: Benabdellah, Karim, et al.
Publicado: (2011)

TOX2 coordinates with TET2 to positively regulate central memory differentiation in human CAR T cells
por: Collins, Sierra M., et al.
Publicado: (2023)

Conditioned CAR-T cells by hypoxia-inducible transcription amplification (HiTA) system significantly enhances systemic safety and retains antitumor efficacy
por: He, Huan, et al.
Publicado: (2021)

Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell Malignancies
por: Guercio, Marika, et al.
Publicado: (2021)

Efficacy and safety of CD19-specific CAR-T cell-based therapy in secondary central nervous system lymphoma
por: Zhang, Huanxin, et al.
Publicado: (2022)

Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma
por: Gong, Fuxing, et al.
Publicado: (2016)

Endogenous epitope-tagging of Tet1, Tet2 and Tet3 identifies TET2 as a naïve pluripotency marker
por: Pantier, Raphaël, et al.
Publicado: (2019)

Overexpression of OASL upregulates TET1 to induce aberrant activation of CD4(+) T cells in systemic sclerosis via IRF1 signaling
por: Zeng, Zhuotong, et al.
Publicado: (2022)

Targeted DNA demethylation of the Arabidopsis genome using the SunTag-dCpf1-TET1cd system
por: Zheng, Yunxi, et al.
Publicado: (2023)

Noise-Reduction and Sensitivity-Enhancement of a Sleeping Beauty-Based Tet-On System
por: Saunderson, Sarah C., et al.
Publicado: (2022)

The development of CAR design for tumor CAR-T cell therapy
por: Xu, Dandan, et al.
Publicado: (2018)

Controlled Transcription of Regulator Gene carS by Tet-on or by a Strong Promoter Confirms Its Role as a Repressor of Carotenoid Biosynthesis in Fusarium fujikuroi
por: Marente, Julia, et al.
Publicado: (2020)

Hypoxia-regulated secretion of IL-12 enhances antitumor activity and safety of CD19 CAR-T cells in the treatment of DLBCL
por: Zhou, Wenping, et al.
Publicado: (2023)

Efficacy and safety of humanized CD19 CAR-T as a salvage therapy for recurrent CNSL of B-ALL following murine CD19 CAR-T cell therapy
por: Li, Xin, et al.
Publicado: (2021)

OGT binds a conserved C-terminal domain of TET1 to regulate TET1 activity and function in development
por: Hrit, Joel, et al.
Publicado: (2018)

Role of Tet proteins in enhancer activity and telomere elongation
por: Lu, Falong, et al.
Publicado: (2014)

Tet protein function during Drosophila development
por: Wang, Fei, et al.
Publicado: (2018)

The Complexity of TET2 Functions in Pluripotency and Development
por: Garcia-Outeiral, Vera, et al.
Publicado: (2021)

Fumaric acid and succinic acid treat gestational hypertension by downregulating the expression of KCNMB1 and TET1
por: Zhou, Yiyuan, et al.
Publicado: (2021)

The clinical study on treatment of CD19‐directed chimeric antigen receptor‐modified T cells in a case of refractory Richter syndrome
por: Xia, Leiming, et al.
Publicado: (2019)

Ascorbic acid induced TET2 enzyme activation enhances cancer immunotherapy efficacy in renal cell carcinoma
por: Peng, Ding, et al.
Publicado: (2022)

TET proteins and the control of cytosine demethylation in cancer
por: Scourzic, Laurianne, et al.
Publicado: (2015)

Nano-Optogenetic Engineering of CAR T-cells for Precision Immunotherapy with Enhanced Safety
por: Nguyen, Nhung Thi, et al.
Publicado: (2021)

Redesigned TetR-Aptamer System To Control Gene Expression in Plasmodium falciparum
por: Rajaram, Krithika, et al.
Publicado: (2020)

Tetracycline-controlled (TetON) gene expression system for the smut fungus Ustilago maydis
por: Ingole, Kishor D., et al.
Publicado: (2022)

Preclinical development of CD126 CAR-T cells with broad antitumor activity
por: Mishra, Ameet K., et al.
Publicado: (2021)

Different Roles for Tet1 and Tet2 Proteins in Reprogramming-Mediated Erasure of Imprints Induced by EGC Fusion
por: Piccolo, Francesco M., et al.
Publicado: (2013)

Different Roles for Tet1 and Tet2 Proteins in Reprogramming-Mediated Erasure of Imprints Induced by EGC Fusion
por: Piccolo, Francesco M., et al.
Publicado: (2013)

Nanog-dependent function of Tet1 and Tet2 in establishment of pluripotency
por: Costa, Yael, et al.
Publicado: (2013)

Prognostic role of high TET1 expression in patients with solid tumors: A meta-analysis
por: Ke, Qiwei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_se1ao82omu1iopf4jcni9331jn